Ravinder Heights Limited (NSE:RVHL)
India
· Delayed Price · Currency is INR | Market Cap | 3.09B |
| Revenue (ttm) | 5.73M |
| Net Income (ttm) | -25.37M |
| Shares Out | 61.33M |
| EPS (ttm) | -0.41 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,503 |
| Average Volume | 35,275 |
| Open | 49.76 |
| Previous Close | 49.99 |
| Day's Range | 49.61 - 51.99 |
| 52-Week Range | 38.52 - 81.90 |
| Beta | -0.17 |
| RSI | 48.50 |
| Earnings Date | Aug 8, 2025 |
About Ravinder Heights
Ravinder Heights Limited engages in the real estate business in India. The company is involved in the acquisition, construction, and development of townships, built-up infrastructure, housing, commercial premises, hotels, resorts, hospitals, educational institutions, recreational facilities, and city and regional level infrastructure. It rents its properties. The company was incorporated in 2019 and is based in New Delhi, India. Ravinder Heights Limited is a subsidiary of Panacea Biotec Limited. [Read more]
Financial Performance
In 2024, Ravinder Heights's revenue was 5.73 million, a decrease of -7.80% compared to the previous year's 6.22 million. Losses were -25.37 million, 17.9% more than in 2023.
Financial StatementsNews
Ravinder Heights shares drop 2% amid land application setback
Ravinder Heights Limited saw its shares drop by 2% following news that its wholly-owned subsidiary, Radhika Heights Limited, and its step-down WOS received an email on December 30, 2024, from Haryana’...